Indeed, the luciferase reporter gene assays showed that ectopic expression of EHF significantly enhanced promoter activities of HER2 and HER3 in thyroid cancer cells, also supported by the ChIP assay. The gene discussed is ERBB2; the disease is thyroid cancer.